US firm gets approval for first-of-a-kind blood thinner in orthopedic surgery patients

WASHINGTON - Johnson & Johnson said Friday that U.S. regulators have approved its new type of blood thinner shown to reduce deadly blood clots in patients who have undergone knee and hip replacements....More